Second Opinion: R&D Is Not To Blame For Skyrocketing Drug Costs
The jig is up – a new report showsthat “the skyrocketing cost of many… Read More
© 2026 CSRXP- All Rights Reserved
CSRxP Welcomes Coalition Against Patent Abuse To Drug Pricing Conversation
The Campaign for Sustainable Rx Pricing (CSRxP) Communications Director Lauren… Read More
Second Opinion: No, Big Pharma Is Not Changing
Right on cue, dozens of pharmaceutical companies rang in the new year by… Read More
With 116th Congress Commencing, CSRxP Announces New Website Launch To Help Lawmakers Address Drug Pricing Crisis
With ‘taking action to lower drug prices’ becoming Americans’ top… Read More
SHOT/CHASER: Analysts Suggest Drug Makers Are Changing Their Ways; Drug Makers Increase Prices By Up To 15 Times Rate Of Inflation
For Immediate Release Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies. Read More
Right On Cue, Drug Companies Begin New Year With Major Price Hikes
For Immediate Release Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies. Read More
CSRxP Responds To Big Pharma’s 2019 Price Hikes
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued… Read More
CSRxP Statement on Meeting with Secretary Azar
For Immediate Release Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies. Read More
CSRxP Statement On The Introduction Of The Hatch-Waxman Integrity Act
For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies… Read More
Second Opinion: Big Pharma’s Back At It
If at first you don’t succeed try, try again. That’s the old adage Big… Read More
Big Pharma Price-Gouging Tactics Contradict Contributions
For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies… Read More
CSRxP Launches Latest Ad In Multi-Phase Campaign Urging Lawmakers To Take Action On Drug Prices
For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies… Read More